Oxytocin for autism spectrum disorder

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 3 Mar 2023: Trial registered, NCT05754073
  2. 1 Aug 2023: Trial started, NCT05754073

The trials

NCT05754073: Oxytocin Effects on Bone in Children With Autism Spectrum Disorder

State
Under way
Phase
Phase 2
People
96 planned
Started
1 Aug 2023
Primary completion
31 Aug 2027
Arms
1. Intranasal Oxytocin
Results
None posted
  1. 3 Mar 2023: Trial registered
  2. 1 Aug 2023: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Oxytocin nasal spray, Pitocin, Syntocinon.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.